Burden of illness imposed by severe sepsis in Switzerland

Swiss Medical Weekly

Volumn 134, Issue 7-8, 2004, Pages 97-102

  Schmid, A ^a   Pugin, F ^b   Chevrolet, F C ^b   Marsch, S ^c   Ludwig, S ^d   Stocker, R ^d   Finnern, H ^e  

^a HealthEcon Ltd   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

Burden of illness; Cost of treatment; Healthcare costs; Intensive care; Sepsis

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEATH; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SEPSIS; STATISTICAL ANALYSIS; SWITZERLAND;

EID: 1442327164     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bernard GR, Vincent J-L, Laterre P-F, LaRosa SP, Dhainaut J-F, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
2. Gyldmark M. A review of costs studies in intensive care units: problems with the cost concept. Crit Care Med 1995;23:964-72.
3. Bone RC. Economic analysis of the intensive care unit: A dilemma. Crit Care Med 1995;23:805.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MG. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
5. Schmid A, Schneider H, Adlof A, Smolle KH, Edelmann G, Sporn P, et al. Economic burden of illness imposed by severe sepsis in Austria. Wien Klin Wochenschr 2002;114/15-16:697-701.
6. Mörer O, Schmid A, Hofmann M, Herklotz A, Reinhart K, Werdan K, et al. Direct costs of severe sepsis patients in three German intensive care units based on retrospective electronic patient record analysis of resource use. Int Care Med 2002;28:1440-6.
7. Schmid A, Burchardi H, Clouth J, Schneider H. Burden of illness imposed by severe sepsis in Germany. Eur Health Econom 2002;3:77-82.
8. Bundesamt für Statistik. Medizinische Statistik der Krankenhäuser 1998. http://www.statistik.admin.ch/stat_ch/ber14/gewe/drfr14a.htm.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, et al. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1656-62.
10. Eidgenössisches Departement des Innern (EDI). Analysenliste. Edition October 1999.
11. Santésuisse. Tagestaxen in Heilanstalten. Edition September 2002.
12. Greiner W. Die Berechnung von Kosten und Nutzen im Gesundheitswesen. In: Schöffski O, Glaser P, Graf v.d. Schulenburg JM, eds. Gesundheitsö konomische Evaluationen. Springer Verlag, Berlin, Heidelberg 1998.
13. Bundesamt für Statistik. Statistisches Jahrbuch der Schweiz 2002. Verlag Neue Zürcher Zeitung, Zürich 2002.
14. Hannoveraner Konsensus Gruppe. Deutsche Empfehlungen zur gesundheits-ökonomischen Evaluationen - Revidierte Fassung des Hannoveraner Konsens. Gesundh ökon Qual manag 1999;4:A62-A65.
15. Desgagné A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmaco Economics 1998;13:487-97.
16. O'Brian BJ, Drummond MF, Labelle RJ, Willin A. In search of power and significance: issues in design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150-63.
17. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published data. BMJ 1998;317:1195-200.
18. Rangel-Frausto S, Pittet D, Hwang T, Woolson RF, Wenzel RP. The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents. Clin Infect Dis 1998;27:185-90.
19. Rangel-Frausto S, Pittet D, Costignan M, Hwag T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome. JAMA 1995;273:117-23.
20. Frutiger A. Qualitätssicherung in der Intensivmedizin: die Situation in der Schweiz. Schweiz Med Wochenschr 1999;129:1592-9.
21. Drummond MF. Studies in economic appraisal in health care, vol 2. Oxford University Press 1986, Oxford New York Tokyo.
22. Drummond MF. Cost of illness studies: a major headache? Pharmaco economics 1992;2:1-4.
23. Balk RA. Severe sepsis and septic shock. Crit Care Clin 2000;16:179-92.
24. Bundesamt für Statistik. Kosten des Gesundheitswesens. Detaillierte Ergebnisse 2001 und Entwicklung seit 1996. BFS, Neuchâtel 2003.
25. Bundesamt für Statistik. Krankenhausstatistik und Statistik der sozialmedizinischen Institutionen 2001. http://www.statistik. admin.ch/stat_ch/ber14/gewe/dtfr14i.htm